Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Profiles of Drug Substances, Excipients, and Related Methodology|May 15, 2013
CarvedilolKevin Beattie, Geeta Phadke, Jasmina Novakovic
Profiles of Drug Substances, Excipients, and Related Methodology|April 23, 2017
Tolterodine TartrateGennady Ananchenko, Jasmina Novakovic
Profiles of Drug Substances, Excipients, and Related Methodology|May 15, 2013
Alendronate sodiumGennady Ananchenko, Jasmina Novakovic, Anna Tikhomirova
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2003
Improved high-performance liquid chromatographic method for the pharmacokinetic studies of a novel iron chelator, CP502, in ratsJasmina Novakovic, Angelo Tesoro, Michael Spino, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 25, 2005
Metabolic and pharmacokinetic evaluation of a novel 3-hydroxypyridinone iron chelator, CP502, in the ratJasmina Novakovic, Angelo Tesoro, Jake J Thiessen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 19, 2005
Validated HPLC assay for iron determination in biological matrices based on ferrioxamine formationAngelo Tesoro, Jasmina Novakovic, Jake J Thiessen, et al.
International Journal of Pharmaceutics|January 20, 2025
In vivo performance of amorphous solid dispersions based on water-insoluble versus water-soluble carriers: Fenofibrate case studyGiovanna C R M Schver, Jasmina Novakovic, Ping I Lee
Journal of Pharmaceutical and Biomedical Analysis|June 1, 2005
Pharmacokinetic studies of a novel 1,2,4-thiadiazole derivative, inhibitor of Factor XIIIa, in the rabbit by a validated HPLC methodJasmina Novakovic, Jolanta Wodzinska, Angelo Tesoro, et al.
AAPS Pharmscitech|February 17, 2024
Predicting Human Dermal Drug Concentrations Using PBPK Modeling and Simulation: Clobetasol Propionate Case StudyWilliam W van Osdol, Jasmina Novakovic, Maxime Le Merdy, et al.
Journal of Pharmaceutical Sciences|September 22, 2021
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case StudiesTycho Heimbach, Filippos Kesisoglou, Jasmina Novakovic, et al.
Pageof 2